3aox
From Proteopedia
(Difference between revisions)
m (Protected "3aox" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:3aox. | + | [[Image:3aox.png|left|200px]] |
<!-- | <!-- | ||
| Line 11: | Line 11: | ||
===X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802=== | ===X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21575866}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21575866 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21575866}} | ||
==About this Structure== | ==About this Structure== | ||
[[3aox]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AOX OCA]. | [[3aox]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AOX OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021575866</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
| Line 20: | Line 29: | ||
[[Category: Moertl, M.]] | [[Category: Moertl, M.]] | ||
[[Category: Nagel, S.]] | [[Category: Nagel, S.]] | ||
| + | [[Category: Alk kinase]] | ||
| + | [[Category: Transferase-transferase inhibitor complex]] | ||
Revision as of 05:07, 4 April 2012
X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802
Template:ABSTRACT PUBMED 21575866
About this Structure
3aox is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Sakamoto H, Tsukaguchi T, Hiroshima S, Kodama T, Kobayashi T, Fukami TA, Oikawa N, Tsukuda T, Ishii N, Aoki Y. CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant. Cancer Cell. 2011 May 17;19(5):679-90. PMID:21575866 doi:10.1016/j.ccr.2011.04.004
